REN and Hypertension resistant to conventional therapy: The concept of Prof. Laragh has recently been confirmed in a study conducted in patients with resistant hypertension (PATHWAY-2), in which the antihypertensive efficacy of drugs acting through the renin–angiotensin system depended on the baseline plasma renin activity [25].